Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Grievous bodily harm.
Carrazana EJ. Carrazana EJ. Neurology. 1996 Nov;47(5):1351. doi: 10.1212/wnl.47.5.1351. Neurology. 1996. PMID: 8909463 No abstract available.
Clarification of dalfampridine labeled indications.
Rabinowicz AL, Carrazana EJ. Rabinowicz AL, et al. J Manag Care Pharm. 2012 Mar;18(2):156. doi: 10.18553/jmcp.2012.18.2.156. J Manag Care Pharm. 2012. PMID: 22380474 Free PMC article. No abstract available.
Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy.
Wheless JW, Miller I, Hogan RE, Dlugos D, Biton V, Cascino GD, Sperling MR, Liow K, Vazquez B, Segal EB, Tarquinio D, Mauney W, Desai J, Rabinowicz AL, Carrazana E; DIAZ.001.05 Study Group. Wheless JW, et al. Among authors: carrazana e. Epilepsia. 2021 Oct;62(10):2485-2495. doi: 10.1111/epi.17041. Epub 2021 Aug 21. Epilepsia. 2021. PMID: 34418086 Free PMC article. Clinical Trial.
Use of second doses of Valtoco® (diazepam nasal spray) across 24 hours after the initial dose for out-of-hospital seizure clusters: Results from a phase 3, open-label, repeat-dose safety study.
Sperling MR, Wheless JW, Hogan RE, Dlugos D, Cascino GD, Liow K, Rabinowicz AL, Carrazana E; DIAZ 001.05 Study Group. Sperling MR, et al. Among authors: carrazana e. Epilepsia. 2022 Apr;63(4):836-843. doi: 10.1111/epi.17177. Epub 2022 Feb 2. Epilepsia. 2022. PMID: 35112342 Free PMC article. Clinical Trial.
Lack of clinically relevant differences in safety and pharmacokinetics after second-dose administration of intranasal diazepam within 4 h for acute treatment of seizure clusters: A population analysis.
Cascino GD, Tarquinio D, Wheless JW, Hogan RE, Sperling MR, Desai J, Vazquez B, Samara E, Misra SN, Carrazana E, Rabinowicz AL; DIAZ.001.05 Study Group. Cascino GD, et al. Among authors: carrazana e. Epilepsia. 2022 Jul;63(7):1714-1723. doi: 10.1111/epi.17249. Epub 2022 Apr 19. Epilepsia. 2022. PMID: 35377464 Free PMC article.
130 results